Associated Papers
Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis.
Kalot MA et al.
Blood Advances, 2022
35192687 (PubMed )
Supplement: advancesADV2021005431C-suppl1.pdf
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A et al.
Medicine, 2016
An update on type 2B von Willebrand disease.
Mikhail S et al.
Expert Review of Hematology, 2014
A novel use of thromboelastography in type 2B von Willebrand disease.
Toukh M et al.
International Journal of Laboratory Hematology, 2013
Genetic testing for von Willebrand disease: the case against.
Favaloro EJ
Journal of Thrombosis and Haemostasis : Jth, 2010
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.
Federici AB et al.
Blood, 2009
Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A et al.
Acta Haematologica, 2009
The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease.
Stakiw J et al.
Journal of Thrombosis and Haemostasis : Jth, 2008
Molecular genetics of type 2 von Willebrand disease.
Fressinaud E et al.
International Journal of Hematology, 2002
Molecular genetics of von Willebrand disease.
Mazurier C et al.
Annales De Genetique, 1998
Select a paper to view details